The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities.
about
Contribution of CXCL12 secretion to invasion of breast cancer cells.Spongiform neurodegeneration-associated E3 ligase Mahogunin ubiquitylates TSG101 and regulates endosomal traffickingEpidermal growth factor receptor potentiates MCM7-mediated DNA replication through tyrosine phosphorylation of Lyn kinase in human cancersActivated Cdc42-associated kinase 1 is a component of EGF receptor signaling complex and regulates EGF receptor degradationBetacellulin inhibits osteogenic differentiation and stimulates proliferation through HIF-1alphaMimotope vaccination--from allergy to cancerSequential and gamma-secretase-dependent processing of the betacellulin precursor generates a palmitoylated intracellular-domain fragment that inhibits cell growthSpecificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signallingLRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT--PCR and immunohistochemical analysisEpidermal growth factor receptor signaling is partially responsible for the increased matrix metalloproteinase-1 expression in ocular epithelial cells after UVB radiationDifferential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skinOncogenic transformation by inhibitor-sensitive and -resistant EGFR mutantsInhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cellsRole of gefitinib in the targeted treatment of non-small-cell lung cancer in Chinese patientsMechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome ItTargeting angiogenesis in gynecologic cancersFluorescent imaging of cancerous tissues for targeted surgery.Molecular biology of gliomas: present and future challengesRole of trastuzumab emtansine in the treatment of HER2-positive breast cancerThe development of immunoconjugates for targeted cancer therapyRegulation of ERBB3/HER3 signaling in cancerEpidermal growth factor receptor inhibitors: coming of ageInsights into HER2 signaling from step-by-step optimization of anti-HER2 antibodiesStructural basis of selectivity and neutralizing activity of a TGFα/epiregulin specific antibodyPhosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFRBeyond RAS and BRAF: a target rich disease that is ripe for pickingCirculating and disseminated tumor cells: diagnostic tools and therapeutic targets in motionOptical imaging probes in oncologyA perspective on anti-EGFR therapies targeting triple-negative breast cancerDevelopmental therapeutics for inflammatory breast cancer: Biology and translational directionsFAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistanceEpidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancerEpidermal growth factor receptor in non-small cell lung cancerTumor-suppressive miR-218-5p inhibits cancer cell proliferation and migration via EGFR in non-small cell lung cancerPhosphorylation of the ErbB3 binding protein Ebp1 by p21-activated kinase 1 in breast cancer cellsAllele Frequencies of the Epidermal Growth Factor Receptors Polymorphism R521K in Colorectal Cancer Patients and Healthy Subjects Indicate a Risk-Reducing Effect of K521 in Syrian PopulationEGFR kinase promotes acquisition of stem cell-like properties: a potential therapeutic target in head and neck squamous cell carcinoma stem cells2,2'-diphenyl-3,3'-diindolylmethane: a potent compound induces apoptosis in breast cancer cells by inhibiting EGFR pathwayExpression of Epidermal Growth Factor Receptor Detected by Cetuximab Indicates Its Efficacy to Inhibit In Vitro and In Vivo Proliferation of Colorectal Cancer CellsQuantitative analysis of ligand-EGFR interactions: a platform for screening targeting molecules
P2860
Q22000754-444C4C56-F3A9-4D51-B856-4367B1D34B87Q24293322-F695D825-097C-4510-8F1D-9A9A27E8E9FCQ24294953-CFA36409-BB40-429A-8C95-154C22CCA171Q24337716-643FE89D-A3D9-4F36-9443-6DAAB059AFE7Q24608282-8C3B77C4-E5A8-466F-BAC0-E993EA6A7E9FQ24608624-68A234F1-6B08-4672-971C-E11F9B29CC9FQ24633569-EE422110-E79E-4C80-9B7A-41F9945BFD92Q24650935-A5603387-424E-49D0-9011-B78A3A592609Q24651229-3955A7D7-201C-4A26-BB39-614197EF720FQ24675409-A92A6405-BDFE-48A7-BBD7-5E7DA9D91B7DQ24683791-A5C18BFE-1426-4531-A784-532FCC208FBEQ24810573-B8436CBC-2FD9-48BB-A483-1901CD4A7D94Q24810622-082B94E2-8361-4219-AD6D-5BAE71F35267Q26750428-3656C8D2-B10C-4D5C-A087-AF4670641CBDQ26752780-27FFF7D0-330D-408B-BEE1-B6709E283293Q26824766-9D9FA9A3-6EA0-4EAB-B76A-E23288227B17Q26830905-1CD7EA88-4A1A-4BE8-A00D-AEBE118A81DBQ27001295-45B2182B-EB87-42CF-89BF-447C1D03EB7CQ27003258-39D3F8E6-2BBD-410E-AB22-6700CA1DC05BQ27021990-3098E40F-57E3-40B7-8D30-C336F6087D32Q27024334-E375F7DB-2EF5-4153-88CA-36033C33037BQ27030769-76EC12BC-640A-4212-8963-A8E45BE513BAQ27683825-CAFC4190-A3FF-4917-8CC2-8EDEE7A69F1AQ27727718-EAC80BC4-6F22-4404-B1E1-D95F5544E66EQ27851872-55C214B6-A277-4D9A-92BF-BF1ABC8D698CQ28066095-E4FE0E9C-F7EB-417F-B733-D76265FB17C8Q28066285-C9AA17C5-4D91-4652-8745-836CD00A7A2CQ28067824-14571A26-8EC8-43E7-850B-700C1BE31E3AQ28069867-EFD38CE3-45C4-4BD7-9C9A-4512E85ED311Q28075322-8575C607-E900-4A5E-B2D6-8DEBEA79DAD0Q28077347-7A05E62D-99E4-40FB-8F4A-B8092B78392FQ28084216-255662D4-293D-4C6E-954D-0E7783C1B089Q28088636-ADEEFCE8-3C94-4F67-8499-DCC6F3B72884Q28115136-F01CE2CE-1399-4112-94F7-C81EBE8FD487Q28269146-F08F1EF2-C976-49C3-83F2-7F21B727BA62Q28397131-5913A47C-10AF-49DE-A94D-4A0C8D7A63CAQ28481290-487C6896-E7C6-4177-AFF3-DDB3CB604423Q28489107-014C6D0A-1FAD-4FDA-8003-2992ACB5E00BQ28534094-E60176D9-861C-465E-A65C-7A0499543C0AQ28543739-F661606F-5388-4061-B3F0-3D5603FE65B7
P2860
The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The EGFR family and its ligand ...... and therapeutic opportunities.
@ast
The EGFR family and its ligand ...... and therapeutic opportunities.
@en
The EGFR family and its ligand ...... and therapeutic opportunities.
@nl
type
label
The EGFR family and its ligand ...... and therapeutic opportunities.
@ast
The EGFR family and its ligand ...... and therapeutic opportunities.
@en
The EGFR family and its ligand ...... and therapeutic opportunities.
@nl
prefLabel
The EGFR family and its ligand ...... and therapeutic opportunities.
@ast
The EGFR family and its ligand ...... and therapeutic opportunities.
@en
The EGFR family and its ligand ...... and therapeutic opportunities.
@nl
P1476
The EGFR family and its ligand ...... and therapeutic opportunities.
@en
P2093
P356
10.1016/S0959-8049(01)00230-1
P478
37 Suppl 4
P577
2001-09-01T00:00:00Z